Mesenchymal Stem Cells Derived Exosomes in Skin Rejuvenation

Launched by ISFAHAN UNIVERSITY OF MEDICAL SCIENCES · Apr 1, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the use of tiny particles called exosomes, derived from mesenchymal stem cells, to help rejuvenate aging skin. Exosomes play an important role in how cells communicate with each other, and researchers believe they may help improve skin health by stimulating the production of collagen, which is essential for keeping skin firm and youthful. The goal of this study is to see if these exosomes can effectively slow down the aging process of the skin.

To participate in the trial, women aged between 35 and 65 who are interested in facial rejuvenation are eligible. However, women who are pregnant, menstruating, or currently using other facial rejuvenation treatments like Botox or chemical peels cannot join. Participants will be part of a study that aims to improve their skin’s appearance, and they can expect to receive specific treatments involving these exosomes. It's important to note that certain health conditions or medications might prevent someone from participating, ensuring the safety and well-being of all involved.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • females
• • Ages 35-65
• • Patients of all racial and ethnic origins
• • Patients of all undergoing facial rejuvenation
• Exclusion Criteria:
• • Female patients in pregnancy or menstrual period
• • Patients undergoing facial rejuvenation using other methods including Botox injections, chemical peels, face lifts and others
• • Patients using blood thinners, aspirin and hormone, that cannot be stopped
• • Patients suffering with severe organic disease, such as coronary heart disease, hypertension, diabetes, lung dysfunction and so on
• • Patients suffering with mental disease, and acute or chronic infectious diseases